Advent France Biotechnology

At AdBio Partners, we invest in and develop the most innovative early-stage startups in life sciences in Europe.

Building the next generation of pioneering life sciences startups AdBio partners is a VC firm with a strong entrepreneurial spirit, specialized in early-stage investment in the most promising life sciences startups in Europe

We explore new territories to source and develop breakthrough medical discoveries across various therapeutic areas and drive inventive European life sciences startups towards success

We work with leading research institutions and well-established technology transfer offices in Europe, with the support of a strong network of scientific & industrial partners and international VC syndicates

We are entrepreneurs and investors

At AdBio partners, we are committed to leading a unique approach as both entrepreneurs and investors

AdBio partners has built a strong team of experts with extensive business, scientific and financial expertise We firmly believe this strategy enables the early identification of the most promising therapeutic innovations to kick-start and grow sustainable startups together with scientific founders and academic institutions

• FEBRUARY 2, 2023 Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrostenosing Crohn’s Disease READ MORE
• DECEMBER 14, 2022 Ribonexus appoints Steven Powell as CEO READ MORE
• OCTOBER 19, 2022 Univercells raises € 44 million in first close of its Series D READ MORE